tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CORT Stock Latest News

Corcept Therapeutics Holds Annual Stockholder Meeting
Company AnnouncementsCorcept Therapeutics Holds Annual Stockholder Meeting
6d ago
8K
CORT
Corcept Therapeutics’ dazucorilant did not meet primary endpoint in ALS study
PremiumThe Fly
Corcept Therapeutics’ dazucorilant did not meet primary endpoint in ALS study
17d ago
CORT
Buy Rating for Corcept Therapeutics Based on Promising Phase III ROSELLA Study Results
PremiumRatings
Buy Rating for Corcept Therapeutics Based on Promising Phase III ROSELLA Study Results
19d ago
CORT
Promising ROSELLA Study Boosts Buy Rating for Corcept Therapeutics with Relacorilant’s Potential in Ovarian Cancer Treatment
PremiumRatings
Promising ROSELLA Study Boosts Buy Rating for Corcept Therapeutics with Relacorilant’s Potential in Ovarian Cancer Treatment
19d ago
CORT
Corcept Therapeutics says Phase 3 ROSELLA trial met primary endpoint
PremiumThe Fly
Corcept Therapeutics says Phase 3 ROSELLA trial met primary endpoint
20d ago
CORT
Corcept Therapeutics: Buy Rating Amid Growth Potential and Strategic Developments
PremiumRatingsCorcept Therapeutics: Buy Rating Amid Growth Potential and Strategic Developments
2M ago
CORT
Corcept Therapeutics’ Earnings Call Highlights Growth Amid Challenges
Premium
Company Announcements
Corcept Therapeutics’ Earnings Call Highlights Growth Amid Challenges
2M ago
CORT
Corcept Therapeutics price target lowered to $135 from $150 at Truist
Premium
The Fly
Corcept Therapeutics price target lowered to $135 from $150 at Truist
2M ago
CORT
Corcept Therapeutics: Strong Growth Potential and Promising Pipeline Support Buy Rating
PremiumRatings
Corcept Therapeutics: Strong Growth Potential and Promising Pipeline Support Buy Rating
2M ago
CORT
Corcept Therapeutics price target lowered to $145 from $150 at H.C. Wainwright
PremiumThe Fly
Corcept Therapeutics price target lowered to $145 from $150 at H.C. Wainwright
2M ago
CORT
Corcept Therapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
Corcept Therapeutics Reports Q1 2025 Financial Results
2M ago
CORT
Closing Bell Movers: Palantir falls 9%, Ford down 2% on earnings
PremiumThe Fly
Closing Bell Movers: Palantir falls 9%, Ford down 2% on earnings
2M ago
F
CE
Corcept Therapeutics Reports Q1 2025 Financial Results
PremiumCompany AnnouncementsCorcept Therapeutics Reports Q1 2025 Financial Results
2M ago
8K
CORT
Corcept Therapeutics reports Q1 EPS 17c, consensus 14c
Premium
The Fly
Corcept Therapeutics reports Q1 EPS 17c, consensus 14c
2M ago
CORT
Corcept Therapeutics options imply 3.7% move in share price post-earnings
Premium
The Fly
Corcept Therapeutics options imply 3.7% move in share price post-earnings
2M ago
CORT
Positive Outlook for Corcept Therapeutics: Buy Rating Backed by Strong Financial Guidance and Pipeline Advancements
PremiumRatings
Positive Outlook for Corcept Therapeutics: Buy Rating Backed by Strong Financial Guidance and Pipeline Advancements
2M ago
CORT
Corcept Therapeutics (CORT) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Corcept Therapeutics (CORT) Q1 Earnings Cheat Sheet
2M ago
CORT
Corcept Therapeutics initiates trial of Phase 2 trial BELLA
PremiumThe Fly
Corcept Therapeutics initiates trial of Phase 2 trial BELLA
3M ago
CORT
Corcept Therapeutics price target raised to $131 from $128 at Piper Sandler
PremiumThe Fly
Corcept Therapeutics price target raised to $131 from $128 at Piper Sandler
3M ago
CORT
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
3M ago
CDT
HUT
Corcept Therapeutics Stock (CORT) Rockets Up 100% After Groundbreaking Cancer Trial Success
Premium
Market News
Corcept Therapeutics Stock (CORT) Rockets Up 100% After Groundbreaking Cancer Trial Success
3M ago
CORT
Corcept Therapeutics price target raised to $142 from $130 at Canaccord
Premium
The Fly
Corcept Therapeutics price target raised to $142 from $130 at Canaccord
3M ago
CORT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >